The present invention relates to a porcine circovirus type-2 (PCV2) subunit vaccine, in particular to a porcine circovirus type-2 (PCV2) immunogenic composition, comprising an antigenic peptide, and also to a method for manufacturing the antigenic peptide encoded by the PCV2 ORF2. The antigenic peptide is selected from a non-arginine-rich peptide and a recombinant fusion protein.
展开▼
